A meta-analysis of randomized, controlled trials compared the use of benzodiazepines alone or in combination with antipsychotic or antihistamine medications in patients experiencing acute psychotic illness.
Exploring Safe and Effective Treatments for Bipolar Depression: Transcranial Direct Current StimulationJanuary 22, 2018
Transcranial direct current stimulation may be an effective add-on treatment for bipolar depression.
Twelve antipsychotics, including olanzapine, ziprasidone, and lurasidone, were examined in a meta-analysis.
Outcomes of long-term CBT in community settings were previously uncertain.
Researchers sought to examine the most efficacious treatment for clinical remission in adults with schizophrenia.
Treating acute pain before it develops into chronic pain may be the key to preventing chronic pain from arising in the first place.
The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.
CDC rank alcohol-attributable mortality as the third leading cause of preventable death in the United States.
One topic of criticism is the relative dearth of scientific evidence regarding the efficacy of 12-step programs.
Approximately 80% of depressive episodes have their onset during the first six months following traumatic brain injury.
Interaction of Proline and COMT Genotype Influences Negative Symptoms in Schizophrenia & Bipolar DisorderSeptember 27, 2016
The authors explored whether valproate (VPA) treatment effects vary by catechol-O-methyltransferase (COMT) genotype.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
Converting just 1 meeting per week to a walking meeting can increase on-the-job activity levels for white-collar workers.
Clinical trials in humans are scheduled to begin later this year.
CDC researchers recommend behavioral modification therapy as treatment for ADHD in children between 2 and 5 years of age.
Poorly managed treatment-resistant schizophrenia has a significant personal and economic impact, with unfavorable long-term outcomes.
Antidepressants were found to be more effective with the concomitant use of nutritional supplements.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders
- Mortality Rates for Substance Use Disorders, Intentional Injuries Vary Widely By Country
- Facial Emotion Recognition Differentiates Behavioral Variant Frontotemporal Dementia From MDD
- The Challenge of Helping Uninsured Patients While Protecting Practice Finances
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed